Related Experiment Video
Updated: Jun 9, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Tumour suppressor function of MDA-7/IL-24 in human breast cancer
Neill Patani1, Anthony Douglas-Jones, Robert Mansel
1Department of Breast Surgery, The London Breast Institute, The Princess Grace Hospital, 42-52 Nottingham Place, W1U-5NY, London, UK. kefahmokbel@hotmail.com.
Introduction:
Melanoma differentiation associated gene-7 (MDA-7), also known as interleukin (IL)-24, is a tumour suppressor gene associated with differentiation, growth and apoptosis. However, the mechanisms underlying its anti-neoplastic activity, tumour-specificity and efficacy across a spectrum of human cancers have yet to be fully elucidated. In this study, the biological impact of MDA-7 on the behavior of breast cancer (BC) cells is evaluated. Furthermore, mRNA expression of MDA-7 is assessed in a cohort of women with BC and correlated with established pathological parameters and clinical outcome.
Methods:
The human BC cell line MDA MB-231 was used to evaluate the in-vitro impact of recombinant human (rh)-MDA-7 on cell growth and motility, using a growth assay, wounding assay and electric cell impedance sensing (ECIS). Localisation of MDA-7 in mammary tissues was assessed with standard immuno-histochemical methodology. BC tissues (n = 127) and normal tissues (n = 33) underwent RNA extraction and reverse transcription, MDA-7 transcript levels were determined using real-time quantitative PCR. Transcript levels were analyzed against tumour size, grade, oestrogen receptor (ER) status, nodal involvement, TNM stage, Nottingham Prognostic Index (NPI) and clinical outcome over a 10 year follow-up period.
Results:
Exposure to rh-MDA-7 significantly reduced wound closure rates for human BC cells in-vitro. The ECIS model demonstrated a significantly reduced motility and migration following rh-MDA-7 treatment (p = 0.024). Exposure to rh-MDA-7 was only found to exert a marginal effect on growth. Immuno-histochemical staining of human breast tissues revealed substantially greater MDA-7 positivity in normal compared to cancer cells. Significantly lower MDA-7 transcript levels were identified in those predicted to have a poorer prognosis by the NPI (p = 0.049) and those with node positive tumours. Significantly lower expression was also noted in tumours from patients who died of BC compared to those who remained disease free (p = 0.035). Low levels of MDA-7 were significantly correlated with a shorter disease free survival (mean = 121.7 vs. 140.4 months, p = 0.0287) on Kaplan-Meier survival analysis.
Conclusion:
MDA-7 significantly inhibits the motility and migration of human BC cells in-vitro. MDA-7 expression is substantially reduced in malignant breast tissue and low transcript levels are significantly associated with unfavourable pathological parameters, including nodal positivity; and adverse clinical outcomes including poor prognosis and shorter disease free survival. MDA-7 offers utility as a prognostic marker and potential for future therapeutic strategies.
Insights
Melanoma differentiation associated gene-7 (MDA-7) inhibits breast cancer cell migration and is less expressed in malignant tissues. Lower MDA-7 levels correlate with poorer prognosis and reduced survival, suggesting its potential as a prognostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Melanoma differentiation associated gene-7 (MDA-7), also known as interleukin (IL)-24, is a tumor suppressor gene.
- Its anti-neoplastic mechanisms, tumor specificity, and efficacy across various cancers require further elucidation.
- This study investigates the biological impact of MDA-7 on breast cancer (BC) cells and its expression correlation with clinical outcomes.
Purpose of the Study:
- To evaluate the in-vitro biological impact of MDA-7 on breast cancer cell behavior.
- To assess MDA-7 mRNA expression in a cohort of women with breast cancer.
- To correlate MDA-7 expression with pathological parameters and clinical outcomes.
Main Methods:
- Utilized the MDA MB-231 human breast cancer cell line to assess the in-vitro effects of recombinant human (rh)-MDA-7 on cell growth and motility.
- Employed wound healing assays, electric cell impedance sensing (ECIS), and immunohistochemistry for MDA-7 localization.
- Analyzed MDA-7 transcript levels via real-time quantitative PCR in 127 breast cancer tissues and 33 normal tissues, correlating with pathological parameters and 10-year clinical outcomes.
Main Results:
- rh-MDA-7 significantly reduced breast cancer cell migration and wound closure in-vitro, with a marginal effect on growth.
- Immunohistochemistry revealed significantly greater MDA-7 positivity in normal breast tissues compared to cancer tissues.
- Lower MDA-7 transcript levels were significantly associated with poorer prognosis (NPI), node-positive tumors, and shorter disease-free survival.
Conclusions:
- MDA-7 significantly inhibits breast cancer cell motility and migration in-vitro.
- MDA-7 expression is substantially reduced in malignant breast tissue.
- Low MDA-7 transcript levels correlate with unfavorable pathological parameters and adverse clinical outcomes, indicating its potential as a prognostic marker and therapeutic target.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

